ForU Holdings Inc
ForU Holdings, Inc., a wellness solutions company, through its subsidiaries, provides nutritional products and healthcare services. The company engages in researching and developing branded consumer products in the health and wellness space, including functional food and beverages; providing a suite of in-home non-medical and medical staffing and services, including light housekeeping and transpo… Read more
ForU Holdings Inc (FORU) - Net Assets
Latest net assets as of September 2011: $-2.17 Million USD
Based on the latest financial reports, ForU Holdings Inc (FORU) has net assets worth $-2.17 Million USD as of September 2011.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.60 Million) and total liabilities ($6.77 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.17 Million |
| % of Total Assets | -47.03% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ForU Holdings Inc - Net Assets Trend (2007–2010)
This chart illustrates how ForU Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ForU Holdings Inc (2007–2010)
The table below shows the annual net assets of ForU Holdings Inc from 2007 to 2010.
| Year | Net Assets | Change |
|---|---|---|
| 2010-12-31 | $-2.65 Million | +22.65% |
| 2009-12-31 | $-3.42 Million | -289.13% |
| 2008-12-31 | $1.81 Million | +440.78% |
| 2007-12-31 | $-530.72K | -- |
Equity Component Analysis
This analysis shows how different components contribute to ForU Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2839425000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2010)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $388.62K | % |
| Other Components | $27.63 Million | % |
| Total Equity | $-2.65 Million | 100.00% |
ForU Holdings Inc Competitors by Market Cap
The table below lists competitors of ForU Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Allied Security Innovations Inc
PINK:ADSV
|
$0.93 |
|
Patient Access Solutions Inc
PINK:PASO
|
$0.93 |
|
Zhejiang Dashang Media Co. Ltd.
PINK:TKVR
|
$0.93 |
|
enherent Corp
PINK:ENHT
|
$0.93 |
|
Gunther Grant Inc
PINK:GNGR
|
$0.92 |
|
ZA Group Inc
PINK:ZAAG
|
$0.92 |
|
New World Gold Cp
PINK:NWGC
|
$0.92 |
|
Universal Systems Inc
PINK:UVSS
|
$0.92 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ForU Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2009 to 2010, total equity changed from -3,420,538 to -2,645,834, a change of 774,704.
- Net loss of 16,027,510 reduced equity.
- Share repurchases of 2,033 reduced equity.
- Other comprehensive income increased equity by 12,065.
- Other factors increased equity by 16,792,182.
Equity Change Factors (2009 to 2010)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-16.03 Million | -605.76% |
| Share Repurchases | $2.03K | -0.08% |
| Other Comprehensive Income | $12.06K | +0.46% |
| Other Changes | $16.79 Million | +634.66% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares ForU Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | $-1.41 | $0.00 | x |
| 2008-12-31 | $3.49 | $0.00 | x |
| 2009-12-31 | $-3.88 | $0.00 | x |
| 2010-12-31 | $-1.37 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ForU Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-20.39%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 0.00% | -1545.00% | 0.16x | 0.00x | $-1.43 Million |
| 2008 | -81.55% | -1415.89% | 0.02x | 3.43x | $-1.66 Million |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-10.55 Million |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-15.76 Million |
Industry Comparison
This section compares ForU Holdings Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ForU Holdings Inc (FORU) | $-2.17 Million | 0.00% | N/A | $0.92 |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |